F2‐02‐02: Studies of neuropathologic and immunologic traits integrate the effect of CR1 and CD33 variants on Alzheimer's‐related amyloid pathology | Zendy

De Jager Philip | Zendy; Bradshaw Elizabeth | Zendy; Chibnik Lori | Zendy; Keenan Brendan | Zendy; Shulman Joshua | Zendy; Schneider Julie | Zendy; Bennett David | Zendy

Premium

F2‐02‐02: Studies of neuropathologic and immunologic traits integrate the effect of CR1 and CD33 variants on Alzheimer's‐related amyloid pathology

Author(s) -

De Jager Philip,

Bradshaw Elizabeth,

Chibnik Lori,

Keenan Brendan,

Shulman Joshua,

Schneider Julie,

Bennett David

Publication year - 2012

Publication title -

alzheimer's and dementia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.713

H-Index - 118

eISSN - 1552-5279

pISSN - 1552-5260

DOI - 10.1016/j.jalz.2012.05.613

Subject(s) - cd33 , microglia , locus (genetics) , allele , immunology , cerebral amyloid angiopathy , biology , medicine , pathology , disease , genetics , gene , dementia , inflammation , stem cell , cd34

IMMUNOLOGIC TRAITS INTEGRATE THE EFFECT OF CR1 AND CD33 VARIANTS ON ALZHEIMER’S-RELATED AMYLOID PATHOLOGY Philip De Jager, Elizabeth Bradshaw, Lori Chibnik, Brendan Keenan, Joshua Shulman, Julie Schneider, David Bennett, Washington University School of Medicine, St. Louis, Missouri, United States; Brigham and Women’s Hospital, Boston, Massachusetts, United States; Rush University, Chicago, Illinois, United States; 4 Rush University Medical Center, Chicago, Illinois, United States.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research